This study demonstrated a significant decrease in TNF‐α and IL‐1β levels, a decrease in insulin secretion, a reduction in insulin resistance symptoms, and an increase in HOMA‐β levels in each intervention group. The gene discussed is IL1B; the disease is Insulin resistance.